Matinas BioPharma Holdings (MTNB) Cash from Investing Activities Growth (5y) (2018 - 2025)
Matinas BioPharma Holdings (MTNB) Cash from Investing Activities Growth (5y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Matinas BioPharma Holdings | 4.60 Mn | 2.15 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -72.23% |
| Dec 31, 2024 | 15.88% |
| Sep 30, 2024 | 166.08% |
| Jun 30, 2024 | -56.01% |
| Mar 31, 2024 | 169.59% |
| Sep 30, 2023 | 42.80% |
| Jun 30, 2023 | 110.22% |
| Mar 31, 2023 | 99.29% |
| Dec 31, 2022 | 18.71% |
| Sep 30, 2022 | 179.39% |
| Dec 31, 2020 | 231.17% |
| Sep 30, 2020 | -186.06% |
| Jun 30, 2020 | 198.71% |
| Mar 31, 2020 | -284.10% |
| Dec 31, 2019 | -2,137.31% |
| Sep 30, 2019 | -19.02% |
| Jun 30, 2019 | -37.58% |
| Mar 31, 2019 | 40.64% |
| Sep 30, 2018 | -57.62% |